131 related articles for article (PubMed ID: 21399877)
1. Proteasome inhibition by MG132 induces growth inhibition and death of human pulmonary fibroblast cells in a caspase-independent manner.
You BR; Park WH
Oncol Rep; 2011 Jun; 25(6):1705-12. PubMed ID: 21399877
[TBL] [Abstract][Full Text] [Related]
2. Mitogen-activated protein kinase inhibitors differently affect the growth inhibition and death of a proteasome inhibitor, MG132-treated human pulmonary fibroblast cells.
Park WH
Hum Exp Toxicol; 2011 Dec; 30(12):1945-54. PubMed ID: 21421692
[TBL] [Abstract][Full Text] [Related]
3. MG132, a proteasome inhibitor, induces human pulmonary fibroblast cell death via increasing ROS levels and GSH depletion.
Park WH; Kim SH
Oncol Rep; 2012 Apr; 27(4):1284-91. PubMed ID: 22266922
[TBL] [Abstract][Full Text] [Related]
4. Arsenic trioxide induces human pulmonary fibroblast cell death via increasing ROS levels and GSH depletion.
You BR; Park WH
Oncol Rep; 2012 Aug; 28(2):749-57. PubMed ID: 22684917
[TBL] [Abstract][Full Text] [Related]
5. Antimycin A induces death of the human pulmonary fibroblast cells via ROS increase and GSH depletion.
Park WH; You BR
Int J Oncol; 2016 Feb; 48(2):813-20. PubMed ID: 26647857
[TBL] [Abstract][Full Text] [Related]
6. The changes of reactive oxygen species and glutathione by MG132, a proteasome inhibitor affect As4.1 juxtaglomerular cell growth and death.
Han YH; Park WH
Chem Biol Interact; 2010 Mar; 184(3):319-27. PubMed ID: 20100472
[TBL] [Abstract][Full Text] [Related]
7. Proteasome inhibitor MG132 reduces growth of As4.1 juxtaglomerular cells via caspase-independent apoptosis.
Han YH; Park WH
Arch Toxicol; 2010 Sep; 84(9):689-98. PubMed ID: 20449726
[TBL] [Abstract][Full Text] [Related]
8. Pyrogallol induces the death of human pulmonary fibroblast cells through ROS increase and GSH depletion.
Park WH
Int J Oncol; 2016 Aug; 49(2):785-92. PubMed ID: 27278810
[TBL] [Abstract][Full Text] [Related]
9. MG132 as a proteasome inhibitor induces cell growth inhibition and cell death in A549 lung cancer cells via influencing reactive oxygen species and GSH level.
Han YH; Park WH
Hum Exp Toxicol; 2010 Jul; 29(7):607-14. PubMed ID: 20053704
[TBL] [Abstract][Full Text] [Related]
10. MAPK inhibitors and siRNAs differentially affect cell death and ROS levels in arsenic trioxide-treated human pulmonary fibroblast cells.
Park WH
Oncol Rep; 2012 May; 27(5):1611-8. PubMed ID: 22293863
[TBL] [Abstract][Full Text] [Related]
11. Treatment with p38 inhibitor intensifies the death of MG132-treated As4.1 juxtaglomerular cells via the enhancement of GSH depletion.
Han YH; Kim SZ; Kim SH; Park WH
Drug Chem Toxicol; 2010 Oct; 33(4):367-76. PubMed ID: 20545600
[TBL] [Abstract][Full Text] [Related]
12. The attenuation of MG132, a proteasome inhibitor, induced A549 lung cancer cell death by p38 inhibitor in ROS-independent manner.
Han YH; Moon HJ; You BR; Park WH
Oncol Res; 2010; 18(7):315-22. PubMed ID: 20377132
[TBL] [Abstract][Full Text] [Related]
13. The effect of MG132, a proteasome inhibitor on HeLa cells in relation to cell growth, reactive oxygen species and GSH.
Han YH; Moon HJ; You BR; Park WH
Oncol Rep; 2009 Jul; 22(1):215-21. PubMed ID: 19513526
[TBL] [Abstract][Full Text] [Related]
14. The effects of N-acetyl cysteine on the MG132 proteasome inhibitor-treated lung cancer cells in relation to cell growth, reactive oxygen species and glutathione.
Han YH; Moon HJ; You BR; Kim SZ; Kim SH; Park WH
Int J Mol Med; 2010 Apr; 25(4):657-62. PubMed ID: 20198316
[TBL] [Abstract][Full Text] [Related]
15. Attenuation of MG132-induced HeLa cell death by N-acetyl cysteine via reducing reactive oxygen species and preventing glutathione depletion.
Han YH; Yang YM; Kim SZ; Park WH
Anticancer Res; 2010 Jun; 30(6):2107-12. PubMed ID: 20651358
[TBL] [Abstract][Full Text] [Related]
16. MG132, a proteasome inhibitor decreased the growth of Calu-6 lung cancer cells via apoptosis and GSH depletion.
Han YH; Park WH
Toxicol In Vitro; 2010 Jun; 24(4):1237-42. PubMed ID: 20149858
[TBL] [Abstract][Full Text] [Related]
17. MAPK inhibitors differentially affect gallic acid-induced human pulmonary fibroblast cell growth inhibition.
Park WH
Mol Med Rep; 2011; 4(1):193-04. PubMed ID: 21461585
[TBL] [Abstract][Full Text] [Related]
18. MG132, a proteasome inhibitor-induced calf pulmonary arterial endothelial cell growth and death, are changed by MAPK inhibitors.
You BR; Park WH
Drug Chem Toxicol; 2011 Jan; 34(1):45-52. PubMed ID: 20954830
[TBL] [Abstract][Full Text] [Related]
19. Gallic acid-induced human pulmonary fibroblast cell death is accompanied by increases in ROS level and GSH depletion.
You BR; Park WH
Drug Chem Toxicol; 2011 Jan; 34(1):38-44. PubMed ID: 20954801
[TBL] [Abstract][Full Text] [Related]
20. Reactive oxygen species and glutathione level changes by a proteasome inhibitor, MG132, partially affect calf pulmonary arterial endothelial cell death.
Han YH; Kim SZ; Kim SH; Park WH
Drug Chem Toxicol; 2010 Oct; 33(4):403-9. PubMed ID: 20088736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]